Drug Profile
Esperamicin-A1
Alternative Names: BBM 1675; BBM 1675A1; BMY 28175Latest Information Update: 18 Feb 1997
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Aminoglycosides; Cytostatic antibiotics; Enediynes; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 Feb 1997 Discontinued-Preclinical for Cancer in Japan (IV)